[HTML][HTML] Plant molecular farming for the production of valuable proteins–Critical evaluation of achievements and future challenges

S Schillberg, R Finnern - Journal of plant physiology, 2021 - Elsevier
Recombinant proteins play an important role in many areas of our lives. For example,
recombinant enzymes are used in the food and chemical industries and as high-quality …

[HTML][HTML] Vaccine-associated enhanced disease and pathogenic human coronaviruses

C Gartlan, T Tipton, FJ Salguero, Q Sattentau… - Frontiers in …, 2022 - frontiersin.org
Vaccine-associated enhanced disease (VAED) is a difficult phenomenon to define and can
be confused with vaccine failure. Using studies on respiratory syncytial virus (RSV) …

[HTML][HTML] A role for Fc function in therapeutic monoclonal antibody-mediated protection against Ebola virus

BM Gunn, WH Yu, MM Karim, JM Brannan… - Cell host & …, 2018 - cell.com
The recent Ebola virus (EBOV) epidemic highlighted the need for effective vaccines and
therapeutics to limit and prevent outbreaks. Host antibodies against EBOV are critical for …

Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus

Q Wang, H Yang, X Liu, L Dai, T Ma, J Qi… - Science translational …, 2016 - science.org
The 2015–2016 outbreak of Zika virus (ZIKV) disease has affected many countries and is a
major public health concern. ZIKV is associated with fetal microcephaly and neurological …

[HTML][HTML] Ebola virus disease: An emerging and re-emerging viral threat

M Rojas, DM Monsalve, Y Pacheco… - Journal of …, 2020 - Elsevier
The genus Ebolavirus from the family Filoviridae is composed of five species including
Sudan ebolavirus, Reston ebolavirus, Bundibugyo ebolavirus, Taï Forest ebolavirus, and …

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open …

MR Gaudinski, EE Coates, L Novik, A Widge… - The Lancet, 2019 - thelancet.com
Background mAb114 is a single monoclonal antibody that targets the receptor-binding
domain of Ebola virus glycoprotein, which prevents mortality in rhesus macaques treated …

[HTML][HTML] Post-exposure treatments for Ebola and Marburg virus infections

RW Cross, CE Mire, H Feldmann… - Nature Reviews Drug …, 2018 - nature.com
The filoviruses—Ebola virus and Marburg virus—cause lethal haemorrhagic fever in
humans and non-human primates (NHPs). Filoviruses present a global health threat both as …

[HTML][HTML] Development of a human antibody cocktail that deploys multiple functions to confer pan-ebolavirus protection

AZ Wec, ZA Bornholdt, S He, AS Herbert, E Goodwin… - Cell host & …, 2019 - cell.com
Passive administration of monoclonal antibodies (mAbs) is a promising therapeutic
approach for Ebola virus disease (EVD). However, all mAbs and mAb cocktails that have …

[HTML][HTML] Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses

JC Milligan, CW Davis, X Yu, PA Ilinykh, K Huang… - Cell, 2022 - cell.com
Several ebolaviruses cause outbreaks of severe disease. Vaccines and monoclonal
antibody cocktails are available to treat Ebola virus (EBOV) infections, but not Sudan virus …

[HTML][HTML] A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates

ZA Bornholdt, AS Herbert, CE Mire, S He, RW Cross… - Cell host & …, 2019 - cell.com
Recent and ongoing outbreaks of Ebola virus disease (EVD) underscore the unpredictable
nature of ebolavirus reemergence and the urgent need for antiviral treatments …